HempNewsBreaks – FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Advances Final Tranche for Buildout of Refined Resin Facility
Royalty company for the U.S. licensed medical cannabis industry FinCanna Capital (CSE: CALI) (OTCQB: FNNZF) today announced its advancement of $750,000 to investee company Refined Resin Technologies Inc., an Oakland, California-based cannabinoid research and extraction company. This is FinCanna’s third and final tranche of its $3 million capital commitment to Refined Resin to fund the build out and operationalization of its 6,000 square foot, state-of-the-art medical cannabis extraction laboratory. “We are very pleased to see the company hitting key milestones as it moves towards full commercialization,” FinCanna Capital President and CEO Andriyko Herchak stated in the news release. “With its…